Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model

Yushi Qiu; Zhimin Li; Frederic Pouzoulet; Prakash Vishnu; John A III Copland; Keith L Knutson; Carole Soussain; Han W Tun

doi:10.1111/bjh.15009

Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model

Yushi Qiu, Zhimin Li, Frederic Pouzoulet, Prakash Vishnu, John A III Copland, Keith L Knutson, Carole Soussain, Han W Tun

Research output: Contribution to journal › Article

4 Scopus citations

Original language	English (US)
Journal	British Journal of Haematology
DOIs	https://doi.org/10.1111/bjh.15009
State	Accepted/In press - 2017

Keywords

Anti-PDCD1 (anti-PD1)
CD274 (PD-L1)
PDCD1LG2 (PD-L2)
Primary central nervous system lymphoma (PCNSL)
Survival

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.15009

Cite this

Qiu, Y., Li, Z., Pouzoulet, F., Vishnu, P., Copland, J. A. III., Knutson, K. L., Soussain, C., & Tun, H. W. (Accepted/In press). Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model. British Journal of Haematology. https://doi.org/10.1111/bjh.15009

Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model. / Qiu, Yushi; Li, Zhimin; Pouzoulet, Frederic; Vishnu, Prakash; Copland, John A III ; Knutson, Keith L; Soussain, Carole; Tun, Han W.

In: British Journal of Haematology, 2017.

Research output: Contribution to journal › Article

Qiu, Yushi ; Li, Zhimin ; Pouzoulet, Frederic ; Vishnu, Prakash ; Copland, John A III ; Knutson, Keith L ; Soussain, Carole ; Tun, Han W. / Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model. In: British Journal of Haematology. 2017.

@article{113c00e485534495b086aba3df1e88bb,

title = "Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model",

keywords = "Anti-PDCD1 (anti-PD1), CD274 (PD-L1), PDCD1LG2 (PD-L2), Primary central nervous system lymphoma (PCNSL), Survival",

author = "Yushi Qiu and Zhimin Li and Frederic Pouzoulet and Prakash Vishnu and Copland, {John A III} and Knutson, {Keith L} and Carole Soussain and Tun, {Han W}",

year = "2017",

doi = "10.1111/bjh.15009",

language = "English (US)",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model

AU - Qiu, Yushi

AU - Li, Zhimin

AU - Pouzoulet, Frederic

AU - Vishnu, Prakash

AU - Copland, John A III

AU - Knutson, Keith L

AU - Soussain, Carole

AU - Tun, Han W

PY - 2017

Y1 - 2017

KW - Anti-PDCD1 (anti-PD1)

KW - CD274 (PD-L1)

KW - PDCD1LG2 (PD-L2)

KW - Primary central nervous system lymphoma (PCNSL)

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85032292240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032292240&partnerID=8YFLogxK

U2 - 10.1111/bjh.15009

DO - 10.1111/bjh.15009

M3 - Article

C2 - 29076134

AN - SCOPUS:85032292240

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -